Reversed reverse remodeling: can biomonitoring solve the clinical conundrum of the 3Rs?
From the Division of Cardiology, Massachusetts General Hospital, Boston (J.L.J.); and the Division of Cardiology, Department of Medicine, St Louis University School of Medicine, MO (P.J.H.). JJanuzzi@partners.org.
James L
JL
Januzzi
From the Division of Cardiology, Massachusetts General Hospital, Boston (J.L.J.); and the Division of Cardiology, Department of Medicine, St Louis University School of Medicine, MO (P.J.H.).
Paul J
PJ
Hauptman
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D008297:Male; D013318:Stroke Volume / Q000502:physiology*; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy* / Q000503:physiopathology*
D000319:Adrenergic beta-Antagonists
Editorials; drug therapy; heart failure